top of page

By:

Quaid Najmi

4 January 2025 at 3:26:24 pm

AI’s Maharaja smiles joyfully

All 30 grounded aircrafts now fly Mumbai : Air India’s Maharaja is all pleased as punch at 80. After years of huge costs and efforts, the last of the grounded 30 aircraft – inherited by the Tata Group during the privatization in Jan. 2022 – is now resurrected fully and took to the skies gracefully on Monday.   The aircraft is the gleaming VT-ALL, a Boeing 777-300ER, that was gathering grime since February 2020, and becomes the final among the two-and-half dozen aircraft that have been revved...

AI’s Maharaja smiles joyfully

All 30 grounded aircrafts now fly Mumbai : Air India’s Maharaja is all pleased as punch at 80. After years of huge costs and efforts, the last of the grounded 30 aircraft – inherited by the Tata Group during the privatization in Jan. 2022 – is now resurrected fully and took to the skies gracefully on Monday.   The aircraft is the gleaming VT-ALL, a Boeing 777-300ER, that was gathering grime since February 2020, and becomes the final among the two-and-half dozen aircraft that have been revved up and revived in the past few years, AI official sources said.   It marked a symbolic milestone for Air India itself - founded in 1932 by the legendary Bharat Ratna J. R. R. Tata - which once ruled the roost and was India’s pride in the global skies.   Once renowned for its royal service with the iconic Maharaja welcoming fliers on board, in 1953 it was taken over by the government of India. After years of piling losses, ageing aircraft, decline in operations and standards – almost like a Maharaja turning a pauper - it returned to the Tata Group four years ago.   This time it was not just the aircraft, the brand and the deflated Maharaja coming into the large-hearted Tata Group stables, but a formidable challenge to ensure that the airline could regain its old glory and glitter. Of the total around 190 aircraft in its fleet were 30 – or 15 pc – that had been grounded and neglected for years.   At that time, the late Ratan N. Tata had directed that all these valuable aircraft must be revived as far as possible and join the fleet. Accordingly, the VT-ALL, languishing at Nagpur for nearly five years, was ‘hospitalized’ at the Air India Engineering Service Ltd., its MRO facility in May 2025.   New Avatar Then started a thorough, painstaking nose-to-tail restoration of an unprecedented scale, in which over 3000 critical components were replaced, over 4,000 maintenance tasks executed, besides key structural upgrades like the longeron modification, engines, auxiliary power units, avionics, hydraulics, landing gears and almost every vital system was rebuilt or replaced.   After the repairs, the old aircraft was reborn, under the gaze of the Directorate General of Civil Aviation and technical assistance from Boeing, and the new ‘avatar’ jetliner emerged with the highest global safety standards.   The aircraft cleared all the rigorous checks, a successful test flight, earned the mandatory Airworthiness Review Certificate and then made its maiden commercial flight from Monday, March 16 – after a wait of six years.   Sturdy Fliers Created in 1946 to become an instant global icon, the Air India’s mascot Maharaja now sports a youthful and chic look, a welcome with folded hands, closed eyes, featuring a bejewelled turban, stylish jootis, and a textured kurta in Air India’s new colours. He is prominently visible at various touch-points in a flyer’s journey, such as First Class, exclusive lounges, and luxury products.   Today, he commands a mix fleet of around 190 narrow and wide-body Airbus and Boeing aircraft like : A319, A320, A320neo, A321, A321neo, A350-900 and B787-8, B787-9, B7770200LR, B-777-300ER. With the merger of Vistara and agreements signed for 10 A350 and 90 A320 aircraft, the Maharaja’s fleet is slated to soar to some 570 in the near future.

Reimagining Boundaries: In Defence of AYUSH Practitioners

India’s health-care shortage will not be fixed by keeping its traditional healers on the margins.

A recent critique of AYUSH practitioners in an article in The Hindu (July 29) titled ‘The medical boundaries for AYUSH practitioners’ by Dinesh S Thakur and Prashant Reddy T presents a detailed but one-sided argument against expanding the scope of practice for AYUSH professionals. While it raises concerns about patient safety and regulatory clarity, it ignores India’s healthcare realities, the history of medical education and the progress of integrative models. It is quite unfair to call the syllabus for Ayurveda students “an absolute mish-mash of concepts” and to say “there is no middle ground between both systems of medicine” when recent research shows that many AYUSH concepts have influenced modern medicine, including advanced areas such as nanomedicine and personalized medicine.


The key question is whether AYUSH practitioners should be allowed to prescribe certain modern medicines or perform specific procedures. Limiting this discussion to legal or doctrinal terms ignores the ground realities. In many districts, a single government allopathic doctor may be responsible for thousands of people. AYUSH doctors are often the first, and sometimes the only, available source of care. Preventing them from dispensing a limited list of essential drugs, ordering diagnostic tests, or making timely referrals can lead to delayed or missed treatment for people in areas with very limited medical facilities. Likewise, questioning whether “practitioners of Ayurveda can refer to themselves as doctors” is at odds with Indian law. The government should take constructive steps to provide appropriate training to AYUSH practitioners for the benefit of citizens and adopt a clear policy position. Yet, in recent Parliament discussions, the Ministry of AYUSH stated there are no plans to officially authorize AYUSH doctors with additional training to prescribe a limited range of essential allopathic medicines. This is despite the well-known fact that rural areas face a serious shortage of allopathic doctors. In many such regions, posts for allopathic doctors remain vacant for years because they are often unwilling to serve there, leaving communities with little or no access to timely medical care.


The Bhore Committee’s doubts about traditional systems are often seen as a standard for legitimacy. But its thinking reflected colonial priorities and the unquestioning adoption of Western models. These models took root partly because, for centuries, caste hierarchies in India allowed almost only Brahmin men to access Ayurveda education, preventing women and people from other communities from entering the field. When Western medicine arrived with standardized syllabi, examinations, hospitals, and wider opportunities for women and non-elite groups, it displaced an unequal system. Acknowledging this history does not diminish Ayurveda; it explains why reforms were needed and why today’s AYUSH education is more inclusive and structured.


Legal recognition has also evolved. The Indian Medicine Central Council Act, 1970, formally recognized Indian systems of medicine and created a national regulator. This has since become the National Commission for Indian System of Medicine (NCISM), with clearer licensing standards, model syllabi, and practitioner registers. It is a structured, quality-focused system, not a permissive one.


Criticism of State notifications under Rule 2(ee) of the Drugs and Cosmetics Rules, 1945, which allow certain AYUSH practitioners to prescribe a limited set of modern medicines, misses the real purpose behind these orders. They are a practical response to the lack of MBBS doctors in many areas. The focus should not be on questioning whether such powers should be given at all, but on ensuring they are exercised responsibly. This means having clear lists of permitted drugs, making training compulsory, keeping proper records of prescriptions, and imposing strict penalties for any misuse. Such measures can protect patient safety while also improving access to care.


It is also wrong to say AYUSH education is detached from modern science. Current BAMS, BHMS, and other AYUSH courses include anatomy, physiology, pathology, pharmacology, microbiology, diagnostics, and public health. While quality may vary between universities, the trend is toward stronger scientific foundations and more clinical exposure. This should continue through regular curriculum updates, standard setting, and independent reviews.


The debate on surgery needs more careful consideration. Ayurveda’s Sushruta Samhita shows a long tradition of surgical knowledge. Any permission for AYUSH surgeons to perform certain procedures should depend on skill, patient types, facilities, and supervision. While some Ayurved students have limited surgical training, the solution is not exclusion but better training by using experienced surgeons as mentors, shared skills labs, standardized assessments, and accredited departments with adequate case load and good outcomes before allowing independent practice. NCISM can lead this with transparent accreditation and periodic re-credentialing.


At the heart of the legal debate is also the issue of protecting their own professional position. Many in the allopathic community welcome integration when AYUSH practitioners work under their supervision, but resist it when it involves equal recognition and shared responsibilities. Patient safety must remain the top priority, but it can be better protected through clearly defined scopes of practice, uniform minimum standards, and joint training programmes, rather than by imposing blanket bans.


Modern healthcare already uses knowledge from different systems. The important question is what works, for whom, in which situations, and at what risk. The World Health Organization supports the role of traditional medicine in universal health coverage, provided countries regulate it well, fund research, and integrate it responsibly. India has moved in this direction by hosting the Global Centre for Traditional Medicine. The next steps are strong clinical research, monitoring drug safety, reporting adverse events across systems, and measuring outcomes in a transparent way.


It is time to move beyond the false choice between science and tradition. India’s healthcare future depends on combining the strengths of both, with decisions guided by solid evidence, ethical practice, and accountability. With proper training and oversight, AYUSH practitioners can deliver timely, culturally appropriate and safe care, particularly in areas where medical services are scarce. Excluding them simply because they follow a different system serves neither the cause of science nor the needs of society.


(Dr. Asmita Wele is Director, Research, College of Ayurved and Research Centre, D.Y. Patil Vidyapeeth, Pimpri-Pune; Dr. Kishore Paknikar is former Director, Agharkar Research Institute and Visiting Professor, IIT Bombay. Views personal.)

Comments


bottom of page